Literature DB >> 27867991

Connecting enterovirus infection to dystrophin dysfunction in dilated cardiomyopathy.

Qiongling Wang1, Xander H T Wehrens2.   

Abstract

Entities:  

Year:  2016        PMID： 27867991      PMCID： PMC5104620          DOI： 10.21037/atm.2016.10.06

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  16 in total

1.  Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.

Authors:  C Badorff; G H Lee; B J Lamphear; M E Martone; K P Campbell; R E Rhoads; K U Knowlton
Journal:  Nat Med       Date:  1999-03       Impact factor: 53.440

2.  Patterns of left ventricular remodeling in patients with Duchenne Muscular Dystrophy: a cardiac MRI study of ventricular geometry, global function, and strain.

Authors:  Wojciech Mazur; Kan N Hor; Joshua T Germann; Robert J Fleck; Hussein R Al-Khalidi; Janaka P Wansapura; Eugene S Chung; Michael D Taylor; John L Jefferies; D Woodrow Benson; William M Gottliebson
Journal:  Int J Cardiovasc Imaging       Date:  2011-01-08       Impact factor: 2.357

3.  Prevalence and mortality rate of congestive heart failure in the United States.

Authors:  D D Schocken; M I Arrieta; P E Leaverton; E A Ross
Journal:  J Am Coll Cardiol       Date:  1992-08       Impact factor: 24.094

4.  Severe dystrophic cardiomyopathy caused by the enteroviral protease 2A-mediated C-terminal dystrophin cleavage fragment.

Authors:  Matthew S Barnabei; Frances V Sjaastad; DeWayne Townsend; Fikru B Bedada; Joseph M Metzger
Journal:  Sci Transl Med       Date:  2015-07-01       Impact factor: 17.956

5.  Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes.

Authors:  R Wessely; A Henke; R Zell; R Kandolf; K U Knowlton
Journal:  Circulation       Date:  1998-08-04       Impact factor: 29.690

6.  Inhibition of CaMKII phosphorylation of RyR2 prevents inducible ventricular arrhythmias in mice with Duchenne muscular dystrophy.

Authors:  Sameer Ather; Wei Wang; Qiongling Wang; Na Li; Mark E Anderson; Xander H T Wehrens
Journal:  Heart Rhythm       Date:  2012-12-12       Impact factor: 6.343

Review 7.  Animal models of arrhythmogenic cardiomyopathy.

Authors:  Mark D McCauley; Xander H T Wehrens
Journal:  Dis Model Mech       Date:  2009 Nov-Dec       Impact factor: 5.758

8.  Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy.

Authors:  Anna Rahnefeld; Karin Klingel; Anett Schuermann; Nicola L Diny; Nadine Althof; Anika Lindner; Philipp Bleienheuft; Konstantinos Savvatis; Dorota Respondek; Elisa Opitz; Lars Ketscher; Martina Sauter; Ulrike Seifert; Carsten Tschöpe; Wolfgang Poller; Klaus-Peter Knobeloch; Antje Voigt
Journal:  Circulation       Date:  2014-08-27       Impact factor: 29.690

Review 9.  Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy.

Authors:  M J Sole; P Liu
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

Review 10.  Current understanding of molecular pathology and treatment of cardiomyopathy in duchenne muscular dystrophy.

Authors:  Tirsa L E van Westering; Corinne A Betts; Matthew J A Wood
Journal:  Molecules       Date:  2015-05-15       Impact factor: 4.411
View more
  1 in total

Review 1.  From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities.

Authors:  Navin Suthahar; Wouter C Meijers; Herman H W Silljé; Rudolf A de Boer
Journal:  Curr Heart Fail Rep       Date:  2017-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.